188 related articles for article (PubMed ID: 24160943)
1. Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B.
Lei J; Wang Y; Wang LL; Zhang SJ; Chen W; Bai ZG; Xu LY
Virol J; 2013 Oct; 10():313. PubMed ID: 24160943
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China.
Qian F; Qin J; Li D; Ma Z; Zhang H; Jin F; Wang W
J Infect Dev Ctries; 2016 Sep; 10(9):996-1002. PubMed ID: 27694733
[TBL] [Abstract][Full Text] [Related]
3. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
[TBL] [Abstract][Full Text] [Related]
4. Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016).
Zhang HY; Liu LG; Ye CY; Chen CH; Hang SX; Zhu Z; Shen HY; Huang ZY; Chen WY; Xue Y
Virus Genes; 2018 Feb; 54(1):41-47. PubMed ID: 29119303
[TBL] [Abstract][Full Text] [Related]
5. Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues.
Wang F; Wang H; Shen H; Meng C; Weng X; Zhang W
Clin Ther; 2009 Feb; 31(2):360-6. PubMed ID: 19302908
[TBL] [Abstract][Full Text] [Related]
6. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.
Liu Y; Wang C; Zhong Y; Li X; Dai J; Ren X; Xu Z; Li L; Yao Z; Ji D; Wang L; Zhang L; Wong VW; Zoulim F; Xu D
J Viral Hepat; 2011 Apr; 18(4):e29-39. PubMed ID: 21392168
[TBL] [Abstract][Full Text] [Related]
7. [Mutation analysis of the HBV reverse transcriptase in nucleos(t)ide-treated patients with chronic HBV infection].
Jiao XJ; Peng X; Jiao XM; Wang JS; Sun XW; Zhao PL; Wang SY; Liu JQ; Li T; Yang JX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):453-5. PubMed ID: 23627028
[TBL] [Abstract][Full Text] [Related]
8. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China.
Zhao Y; Wu J; Sun L; Liu G; Li B; Zheng Y; Li X; Tao J
Braz J Infect Dis; 2016; 20(2):173-8. PubMed ID: 26876337
[TBL] [Abstract][Full Text] [Related]
10. Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility.
Fan J; Wang Y; Xiong H; Guo X; Cheng YC
J Gen Virol; 2014 Nov; 95(Pt 11):2523-2530. PubMed ID: 25028473
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
Li XG; Liu BM; Xu J; Liu XE; Ding H; Li T
J Med Virol; 2012 Feb; 84(2):207-16. PubMed ID: 22170539
[TBL] [Abstract][Full Text] [Related]
12. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
Ji FZ; Wang L; Yang BH; Zhao JJ; Liu F; Xue Y; Li T
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149
[TBL] [Abstract][Full Text] [Related]
14. [Drug-resistant mutations in hepatitis B virus found in chronic HBV carriers using PCR sequencing technology].
Jiang B; Dai CY; Li XM; Su R; Xu J; Cao Y; Hou W; Lu W
Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):36-9. PubMed ID: 26983387
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.
Luo Q; Zhong Y; Yang Y; Xiong Q; Hu Z; Lu W; Huang P; Zhang N
J Med Virol; 2012 Oct; 84(10):1558-61. PubMed ID: 22930503
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy.
Kim SS; Cho SW; Kim SO; Hong SP; Cheong JY
J Med Virol; 2013 Jan; 85(1):55-64. PubMed ID: 23096938
[TBL] [Abstract][Full Text] [Related]
17. rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy.
Lee YS; Chung YH; Kim JA; Jin YJ; Park WH; Kim SE; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2012 Feb; 27(2):300-5. PubMed ID: 21777282
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of therapy in patients with chronic hepatitis B virus.
Arrese E; Basaras M; Blanco S; Ruiz P; Cisterna R
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
[TBL] [Abstract][Full Text] [Related]
19. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
Mirandola S; Sebastiani G; Rossi C; Velo E; Erne EM; Vario A; Tempesta D; Romualdi C; Campagnolo D; Alberti A
Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
[TBL] [Abstract][Full Text] [Related]
20. De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine.
Yang S; Xing H; Wang Q; Wang X; Liu S; Cheng J
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():24. PubMed ID: 27079793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
